CytoSorbents Corporation (CTSO)

[techxen]

Biocon case report - Viper snake bite

Interesting report on what appears the first case of Cytosorb used for a snake bite resulting in sepsis and multiple organ failure.

A CASE OF VIPER SNAKE BITE PRESENTING WITH GANGRENE AND SEPSIS ASSOCIATED
MULTIORGAN FAILURE, SUCCESSFULLY TREATED WITH CYTOSORB® AS AN ADJUNCT
THERAPY- A CLINICAL EXPERIENCE
February 5, 2018

Viper snake bites are known to cause local complications
like necrosis and cellulitis and systemic complications such
as coagulopathy, acute renal failure (ARF), and haemolysis.
We report a case of 32-year young male patient who was
bitten by a viper. He developed cellulitis, sepsis, acute
renal failure, and disseminated intravascular coagulation
(DIC). Patient also developed acute respiratory distress
syndrome (ARDS) probably due to the direct toxic effect of
venom on pulmonary vascular endothelium. He was treated
with standard care of treatment along with a novel
extracorporeal cytokine adsorption device Cytosorb® as an
adjunct therapy. After Cytosorb® treatment, all his renal,
haematological and respiratory parameters returned to
normal. The post-Cytosorb® APACHE II and SOFA score
was reduced to 11 and 8 from a baseline value of 29 and
15 respectively.

https://jebmh.com/assets/data_pdf/Rajib_Paul_-_FINAL.pdf